文献速递泌尿生殖腹部MR

mpMRI检测的肿瘤表观扩散系数与根治性前列腺切除术后5年生化复发风险的相关性

Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy.
PubMed 文献 · Radiol Med · 2024-07-16

回顾性分析1439例根治性前列腺切除术前接受mpMRI的前列腺癌患者,评估肿瘤ADC值与术后5年生化复发(BCR)的关系。外周带癌患者ADC越低BCR风险越高,低/中/高ADC组5年无BCR生存率分别为52.3%、74.4%、87%;非外周带癌未见此关联。作者认为外周带癌的肿瘤ADC值可预测5年BCR风险,可能作为预后生物标志物。

要点

  • 外周带前列腺癌肿瘤ADC值越低,根治性前列腺切除术后5年生化复发风险越高。
  • 低、中、高ADC组5年无BCR生存率分别为52.3%、74.4%、87%(p<0.0001)。
  • 非外周带前列腺癌患者中未观察到ADC与BCR的关联。

核心结论

  • 肿瘤ADC值及ADC分类可预测外周带前列腺癌患者根治性前列腺切除术后5年BCR风险,可能作为预后生物标志物。
  • 非外周带前列腺癌患者中未观察到ADC与BCR的关联。

研究设计与样本

  • 回顾性分析纳入1207例外周带和232例非外周带前列腺癌患者,均于根治性前列腺切除术前接受mpMRI(2012—2015年),结局为5年BCR。
  • ADC作为连续变量及分类变量评估:低(<850 µm2/s)、中(850–1100 µm2/s)、高(>1100 µm2/s)。
  • 采用Kaplan-Meier曲线及log-rank检验比较无BCR生存,多变量Cox比例风险回归模型估计BCR风险。

诊断标准与关键数值

  • ADC分类阈值:低<850 µm2/s、中850–1100 µm2/s、高>1100 µm2/s。
  • 发生BCR的外周带癌患者肿瘤ADC值低于未发生BCR者(874 vs 1025 µm2/s,p<0.001)。
  • 低、中、高ADC组5年无BCR生存率分别为52.3%、74.4%、87%(p<0.0001)。
  • ADC作为连续变量与BCR相关(HR 5.35,p<0.001);ADC分类中,中vs高ADC的HR为1.56(p=0.017),低vs高ADC的HR为2.36(p<0.001)。

临床应用与阅片要点

  • 在外周带前列腺癌的mpMRI报告中,可记录肿瘤ADC值并按低(<850 µm2/s)、中(850–1100 µm2/s)、高(>1100 µm2/s)分类,以辅助术后BCR风险分层。
  • 非外周带前列腺癌中ADC与BCR未见关联,解读该区域ADC时需结合原文结论。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the ability of tumor apparent diffusion coefficient (ADC) values obtained from multiparametric magnetic resonance imaging (mpMRI) to predict the risk of 5-year biochemical recurrence (BCR) after radical prostatectomy (RP).

MATERIALS AND METHODS: This retrospective analysis included 1207 peripheral and 232 non-peripheral zone prostate cancer (PCa) patients who underwent mpMRI before RP (2012-2015), with the outcome of interest being 5-year BCR. ADC was evaluated as a continuous variable and as categories: low (< 850 µm2/s), intermediate (850-1100 µm2/s), and high (> 1100 µm2/s). Kaplan-Meier curves with log-rank testing of BCR-free survival, multivariable Cox proportional hazard regression models were formed to estimate the risk of BCR.

RESULTS: Among the 1439 males with median age 63 (± 7) years, the median follow-up was 59 months, and 306 (25%) patients experienced BCR. Peripheral zone PCa patients with BCR had lower tumor ADC values than those without BCR (874 versus 1025 µm2/s, p < 0.001). Five-year BCR-free survival rates were 52.3%, 74.4%, and 87% for patients in the low, intermediate, and high ADC value categories, respectively (p < 0.0001). Lower ADC was associated with BCR, both as continuously coded variable (HR: 5.35; p < 0.001) and as ADC categories (intermediate versus high ADC-HR: 1.56, p = 0.017; low vs. high ADC-HR; 2.36, p < 0.001). In the non-peripheral zone PCa patients, no association between ADC and BCR was observed.

CONCLUSION: Tumor ADC values and categories were found to be predictive of the 5-year BCR risk after RP in patients with peripheral zone PCa and may serve as a prognostic biomarker.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Alessi S, Maggioni R, Luzzago S, et al. Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy. Radiol Med. 2024. PMID: 39014292. doi:10.1007/s11547-024-01857-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。